Europe Adalimumab Biosimilar Market Report 2016

November 2016 | 119 pages | ID: E8F67CDE27CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Adalimumab Biosimilar

Revenue, means the sales value of Adalimumab Biosimilar

This report studies sales (consumption) of Adalimumab Biosimilar in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• AET BioTech
• Amgen
• Boehringer Ingelheim
• Coherus Biosciences
• Fujifilm Kyowa Kirin Biologics
• LG Life Sciences/Mochida Pharmaceutical
• Momenta Pharmaceuticals
• Oncobiologics
• Pfizer
• Samsung Bioepsis
• Sandoz
• Zydus Cadila

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Adalimumab Biosimilar in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Adalimumab Biosimilar in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Adalimumab Biosimilar Market Report 2016

1 ADALIMUMAB BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Classification of Adalimumab Biosimilar
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Adalimumab Biosimilar
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Adalimumab Biosimilar Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Adalimumab Biosimilar (2011-2021)
  1.5.1 Europe Adalimumab Biosimilar Sales and Growth Rate (2011-2021)
  1.5.2 Europe Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)

2 EUROPE ADALIMUMAB BIOSIMILAR BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Adalimumab Biosimilar Market Competition by Manufacturers
  2.1.1 Europe Adalimumab Biosimilar Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Adalimumab Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Adalimumab Biosimilar (Volume and Value) by Type
  2.2.1 Europe Adalimumab Biosimilar Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Adalimumab Biosimilar Revenue and Market Share by Type (2011-2016)
2.3 Europe Adalimumab Biosimilar (Volume and Value) by Countries
  2.3.1 Europe Adalimumab Biosimilar Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Adalimumab Biosimilar Revenue and Market Share by Countries (2011-2016)
2.4 Europe Adalimumab Biosimilar (Volume) by Application

3 GERMANY ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Adalimumab Biosimilar Sales and Value (2011-2016)
  3.1.1 Germany Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  3.1.2 Germany Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Adalimumab Biosimilar Sales Price Trend (2011-2016)
3.2 Germany Adalimumab Biosimilar Sales and Market Share by Manufacturers
3.3 Germany Adalimumab Biosimilar Sales and Market Share by Type
3.4 Germany Adalimumab Biosimilar Sales and Market Share by Application

4 FRANCE ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

4.1 France Adalimumab Biosimilar Sales and Value (2011-2016)
  4.1.1 France Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  4.1.2 France Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  4.1.4 France Adalimumab Biosimilar Sales Price Trend (2011-2016)
4.2 France Adalimumab Biosimilar Sales and Market Share by Manufacturers
4.3 France Adalimumab Biosimilar Sales and Market Share by Type
4.4 France Adalimumab Biosimilar Sales and Market Share by Application

5 UK ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

5.1 UK Adalimumab Biosimilar Sales and Value (2011-2016)
  5.1.1 UK Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  5.1.2 UK Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  5.1.5 UK Adalimumab Biosimilar Sales Price Trend (2011-2016)
5.2 UK Adalimumab Biosimilar Sales and Market Share by Manufacturers
5.3 UK Adalimumab Biosimilar Sales and Market Share by Type
5.4 UK Adalimumab Biosimilar Sales and Market Share by Application

6 RUSSIA ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Adalimumab Biosimilar Sales and Value (2011-2016)
  6.1.1 Russia Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  6.1.2 Russia Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Adalimumab Biosimilar Sales Price Trend (2011-2016)
6.2 Russia Adalimumab Biosimilar Sales and Market Share by Manufacturers
6.3 Russia Adalimumab Biosimilar Sales and Market Share by Type
6.4 Russia Adalimumab Biosimilar Sales and Market Share by Application

7 ITALY ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Adalimumab Biosimilar Sales and Value (2011-2016)
  7.1.1 Italy Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  7.1.2 Italy Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Adalimumab Biosimilar Sales Price Trend (2011-2016)
7.2 Italy Adalimumab Biosimilar Sales and Market Share by Manufacturers
7.3 Italy Adalimumab Biosimilar Sales and Market Share by Type
7.4 Italy Adalimumab Biosimilar Sales and Market Share by Application

8 SPAIN ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Adalimumab Biosimilar Sales and Value (2011-2016)
  8.1.1 Spain Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  8.1.2 Spain Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Adalimumab Biosimilar Sales Price Trend (2011-2016)
8.2 Spain Adalimumab Biosimilar Sales and Market Share by Manufacturers
8.3 Spain Adalimumab Biosimilar Sales and Market Share by Type
8.4 Spain Adalimumab Biosimilar Sales and Market Share by Application

9 BENELUX ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Adalimumab Biosimilar Sales and Value (2011-2016)
  9.1.1 Benelux Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Adalimumab Biosimilar Sales Price Trend (2011-2016)
9.2 Benelux Adalimumab Biosimilar Sales and Market Share by Manufacturers
9.3 Benelux Adalimumab Biosimilar Sales and Market Share by Type
9.4 Benelux Adalimumab Biosimilar Sales and Market Share by Application

10 EUROPE ADALIMUMAB BIOSIMILAR MANUFACTURERS ANALYSIS

10.1 AET BioTech
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Amgen
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Boehringer Ingelheim
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Coherus Biosciences
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Fujifilm Kyowa Kirin Biologics
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 LG Life Sciences/Mochida Pharmaceutical
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Momenta Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Oncobiologics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Pfizer
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Samsung Bioepsis
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Adalimumab Biosimilar Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Sandoz
10.12 Zydus Cadila

11 ADALIMUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

11.1 Adalimumab Biosimilar Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Adalimumab Biosimilar

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Adalimumab Biosimilar Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE ADALIMUMAB BIOSIMILAR MARKET FORECAST (2016-2021)

14.1 Germany Adalimumab Biosimilar Sales Forecast (2016-2021)
14.2 France Adalimumab Biosimilar Sales Forecast (2016-2021)
14.3 UK Adalimumab Biosimilar Sales Forecast (2016-2021)
14.4 Russia Adalimumab Biosimilar Sales Forecast (2016-2021)
14.5 Italy Adalimumab Biosimilar Sales Forecast (2016-2021)
14.6 Spain Adalimumab Biosimilar Sales Forecast (2016-2021)
14.7 Benelux Adalimumab Biosimilar Sales Forecast (2016-2021)
14.8 Europe Adalimumab Biosimilar Sales Forecast by Type (2016-2021)
14.9 Europe Adalimumab Biosimilar Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Adalimumab Biosimilar
Table Classification of Adalimumab Biosimilar
Figure Europe Sales Market Share of Adalimumab Biosimilar by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Adalimumab Biosimilar
Figure Europe Sales Market Share of Adalimumab Biosimilar by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure France Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure UK Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure Russia Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure Italy Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure Spain Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure Benelux Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure Europe Adalimumab Biosimilar Sales and Growth Rate (2011-2021)
Figure Europe Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Table Europe Adalimumab Biosimilar Sales of Key Manufacturers (2015 and 2016)
Table Europe Adalimumab Biosimilar Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Adalimumab Biosimilar Sales Share by Manufacturers
Figure 2016 Adalimumab Biosimilar Sales Share by Manufacturers
Table Europe Adalimumab Biosimilar Revenue by Manufacturers (2015 and 2016)
Table Europe Adalimumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Adalimumab Biosimilar Revenue Share by Manufacturers
Table 2016 Europe Adalimumab Biosimilar Revenue Share by Manufacturers
Table Europe Adalimumab Biosimilar Sales and Market Share by Type (2011-2016)
Table Europe Adalimumab Biosimilar Sales Share by Type (2011-2016)
Figure Sales Market Share of Adalimumab Biosimilar by Type (2011-2016)
Figure Europe Adalimumab Biosimilar Sales Growth Rate by Type (2011-2016)
Table Europe Adalimumab Biosimilar Revenue and Market Share by Type (2011-2016)
Table Europe Adalimumab Biosimilar Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Adalimumab Biosimilar by Type (2011-2016)
Figure Europe Adalimumab Biosimilar Revenue Growth Rate by Type (2011-2016)
Table Europe Adalimumab Biosimilar Sales and Market Share by Countries (2011-2016)
Table Europe Adalimumab Biosimilar Sales Share by Countries (2011-2016)
Figure Sales Market Share of Adalimumab Biosimilar by Countries (2011-2016)
Table Europe Adalimumab Biosimilar Revenue and Market Share by Countries (2011-2016)
Table Europe Adalimumab Biosimilar Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Adalimumab Biosimilar by Countries (2011-2016)
Table Europe Adalimumab Biosimilar Sales and Market Share by Application (2011-2016)
Table Europe Adalimumab Biosimilar Sales Share by Application (2011-2016)
Figure Sales Market Share of Adalimumab Biosimilar by Application (2011-2016)
Figure Germany Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure Germany Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure Germany Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table Germany Adalimumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Germany Adalimumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Germany Adalimumab Biosimilar Sales by Type (2015 and 2016)
Table Germany Adalimumab Biosimilar Market Share by Type (2015 and 2016)
Table Germany Adalimumab Biosimilar Sales by Application (2015 and 2016)
Table Germany Adalimumab Biosimilar Market Share by Application (2015 and 2016)
Figure France Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure France Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure France Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table France Adalimumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table France Adalimumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table France Adalimumab Biosimilar Sales by Type (2015 and 2016)
Table France Adalimumab Biosimilar Market Share by Type (2015 and 2016)
Table France Adalimumab Biosimilar Sales by Application (2015 and 2016)
Table France Adalimumab Biosimilar Market Share by Application (2015 and 2016)
Figure UK Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure UK Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure UK Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table UK Adalimumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table UK Adalimumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table UK Adalimumab Biosimilar Sales by Type (2015 and 2016)
Table UK Adalimumab Biosimilar Market Share by Type (2015 and 2016)
Table UK Adalimumab Biosimilar Sales by Application (2015 and 2016)
Table UK Adalimumab Biosimilar Market Share by Application (2015 and 2016)
Figure Russia Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure Russia Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure Russia Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table Russia Adalimumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Russia Adalimumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Russia Adalimumab Biosimilar Sales by Type (2015 and 2016)
Table Russia Adalimumab Biosimilar Market Share by Type (2015 and 2016)
Table Russia Adalimumab Biosimilar Sales by Application (2015 and 2016)
Table Russia Adalimumab Biosimilar Market Share by Application (2015 and 2016)
Figure Italy Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure Italy Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure Italy Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table Italy Adalimumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Italy Adalimumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Italy Adalimumab Biosimilar Sales by Type (2015 and 2016)
Table Italy Adalimumab Biosimilar Market Share by Type (2015 and 2016)
Table Italy Adalimumab Biosimilar Sales by Application (2015 and 2016)
Table Italy Adalimumab Biosimilar Market Share by Application (2015 and 2016)
Figure Spain Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure Spain Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure Spain Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table Spain Adalimumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Spain Adalimumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Spain Adalimumab Biosimilar Sales by Type (2015 and 2016)
Table Spain Adalimumab Biosimilar Market Share by Type (2015 and 2016)
Table Spain Adalimumab Biosimilar Sales by Application (2015 and 2016)
Table Spain Adalimumab Biosimilar Market Share by Application (2015 and 2016)
Figure Benelux Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure Benelux Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure Benelux Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table Benelux Adalimumab Biosimilar Sales by Manufacturers (2015 and 2016)
Table Benelux Adalimumab Biosimilar Market Share by Manufacturers (2015 and 2016)
Table Benelux Adalimumab Biosimilar Sales by Type (2015 and 2016)
Table Benelux Adalimumab Biosimilar Market Share by Type (2015 and 2016)
Table Benelux Adalimumab Biosimilar Sales by Application (2015 and 2016)
Table Benelux Adalimumab Biosimilar Market Share by Application (2015 and 2016)
Table Adalimumab Biosimilar Basic Information List
Table AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AET BioTech Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Coherus Biosciences Basic Information List
Table Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Coherus Biosciences Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales Market Share (2011-2016)
Table LG Life Sciences/Mochida Pharmaceutical Basic Information List
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Momenta Pharmaceuticals Basic Information List
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oncobiologics Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Samsung Bioepsis Basic Information List
Table Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Bioepsis Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Cadila Adalimumab Biosimilar Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab Biosimilar
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
Table Major Buyers of Adalimumab Biosimilar
Table Distributors/Traders List
Figure Germany Adalimumab Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure Germany Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Figure France Adalimumab Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure France Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Figure UK Adalimumab Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure UK Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Adalimumab Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure Russia Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Adalimumab Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure Italy Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Adalimumab Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure Spain Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Adalimumab Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Table Europe Adalimumab Biosimilar Sales Forecast by Type (2016-2021)
Table Europe Adalimumab Biosimilar Sales Forecast by Application (2016-2021)